Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Receivables - Other (2016 - 2024)

Historic Receivables - Other for Perspective Therapeutics (CATX) over the last 14 years, with Q4 2024 value amounting to $487000.0.

  • Perspective Therapeutics' Receivables - Other rose 477000.0% to $487000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $487000.0, marking a year-over-year increase of 477000.0%. This contributed to the annual value of $487000.0 for FY2024, which is 477000.0% up from last year.
  • As of Q4 2024, Perspective Therapeutics' Receivables - Other stood at $487000.0, which was up 477000.0% from $10000.0 recorded in Q4 2023.
  • In the past 5 years, Perspective Therapeutics' Receivables - Other registered a high of $487000.0 during Q4 2024, and its lowest value of $2000.0 during Q4 2022.
  • For the 5-year period, Perspective Therapeutics' Receivables - Other averaged around $96500.0, with its median value being $24000.0 (2020).
  • In the last 5 years, Perspective Therapeutics' Receivables - Other plummeted by 6395.35% in 2020 and then surged by 477000.0% in 2024.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Receivables - Other stood at $31000.0 in 2020, then increased by 3.23% to $32000.0 in 2021, then plummeted by 93.75% to $2000.0 in 2022, then surged by 400.0% to $10000.0 in 2023, then surged by 4770.0% to $487000.0 in 2024.
  • Its Receivables - Other was $487000.0 in Q4 2024, compared to $10000.0 in Q4 2023 and $2000.0 in Q4 2022.